Table 1.
Patient characteristics.
| Number | 30 |
|---|---|
| Male: Female | 22:8 |
| Age, year | 63.6 ± 12.1 |
| BMI, kg/m2 | 26.8 ± 4.8 |
| Risk factors, number | |
| Hypertension | 19 |
| Diabetes | 7 |
| Dyslipidemia | 13 |
| Smoking | 18 |
| Hyperuricemia | 3 |
| Hemodialysis | 1 |
| COPD | 1 |
| Cardiovascular disease, number | |
| CHF (HFpEF, HHD, OMI, Takotsubo) | 4 |
| pMVR | 1 |
| OMI | 2 |
| AAD | 1 |
| Drugs, number | |
| β-blockers | 6 |
| Ca-blockers | 16 |
| ACE-I/ARB | 10 |
| Diuretics | 6 |
| Statin | 10 |
| Oral diabetic drugs | 6 |
| Insulin | 3 |
The mean ± SD values are shown. Body mass index, BMI; congestive heart failure, COPD; chronic obstructive pulmonary disease, CHF; heart failure with preserved ejection fraction, HFpEF; hypertensive heart disease, HHD; old myocardial infarction, OMI; pMVR; post-mitral valvuloplasty; acute aortic dissection, AAD; angiotensin converting enzyme inhibitor, ACE1, and angiotensin II receptor blocker, ARB.